Illumina Ventures

Illumina Ventures accounts for 15 tracked companies with verified cap-table data, 15 of which disclose round sizes totalling $1.8B. The median disclosed raise is $86M, and the largest is Delfi Diagnostics at $400M, ahead of Encoded Therapeutics ($240M) and SonoThera ($215M).

The names that recur most often on these portfolio cap tables are Illumina Ventures (15 companies), Northpond Ventures (3 companies), Alexandria Venture Investments (3 companies), Menlo Ventures (2 companies), Osage University Partners (2 companies), GV (2 companies). By latest disclosed round, the market skews Series B (5), Series A (4), Series D (2), Series C (1).

• Companies tracked: 15
• Disclosed funding total: $1.8B across 15 companies
• Median disclosed raise: $86M
• Largest raise: Delfi Diagnostics — $400M
• Stage mix: Series B 5 · Series A 4 · Series D 2 · Series C 1
• Most recent dated round: 2026-06-10

Best funded Illumina Ventures companies

1. Delfi Diagnostics — $400M (latest: Series B)
2. Encoded Therapeutics — $240M (latest: Series D)
3. SonoThera — $215M (latest: Series B)
4. SQZ Biotech — $200M (latest: Series D)
5. DNA Script — $112M
6. Sherlock Biosciences — $111M (latest: Series B)
7. Pattern Bioscience — $105M (latest: Series C)
8. NanoCellect Biomedical — $86M (latest: Series AA)
9. Precede Biosciences — $84M (latest: Series B)
10. Memora Health — $81M
11. Actym Therapeutics, Inc. — $60M (latest: Series A)
12. Attovia Therapeutics — $60M (latest: Series A)
13. Genome Medical — $60M (latest: Series B)
14. Walking Fish Therapeutics — $23M (latest: Series A)
15. Infinity Pharmaceuticals — $8M (latest: Series A)

Illumina Ventures — related firms and companies (56)

• Delfi Diagnostics
• Encoded Therapeutics
• SonoThera
• SQZ Biotech
• DNA Script
• Sherlock Biosciences
• Pattern Bioscience
• NanoCellect Biomedical
• Investors like Elemental Impact
• Investors like Betaworks
• Investors like Goldman Sachs
• Investors like Bain Capital Ventures
• Investors like SV Angel
• Companies backed by Illumina Ventures
• Infinity Pharmaceuticals
• Attovia Therapeutics
• Precede Biosciences
• Investors like Torch Capital
• Investors like Floodgate
• Investors like Tiger Global Management
• Investors like True Ventures
• Investors like Khosla Ventures
• Investors like Expansion Venture Capital
• Investors like HSG
• Investors like GSR Ventures
• Investors like FirstMark
• Investors like Atlas Venture
• Investors like SOSV
• Investors like Greylock
• Investors like Founders Fund
• Investors like Illumina Ventures
• Walking Fish Therapeutics
• Actym Therapeutics, Inc.
• Investors like Point72 Ventures
• Investors like ARCH Venture Partners
• Investors like Benchmark
• Investors like Foundation Capital
• Investors like Canaan Partners
• Investors like Casdin Capital
• Investors like Ventioneers
• Investors like CAVU Consumer Partners
• Investors like Fika Ventures
• Investors like Service Provider Capital
• Investors like Meritech Capital Partners
• Investors like Liquid 2 Ventures
• Investors like Alumni Ventures
• Investors like Blockchain Capital
• Illumina Ventures co-investors 2026
• Genome Medical
• Memora Health
• Investors like Foundry Group
• Investors like Eniac Ventures
• Investors like Headline
• Investors like Gaingels
• Investors like Lightspeed Venture Partners
• Investors like Vine Ventures

Illumina Ventures profile · All research reports